The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 2×
“We also used two inflammation models, e.g., a skin psoriasis model and an inflammatory bowel disease model, since inflammatory disorders are characterized by increased angiogenesis (Wynn et al., 2013).”
BackgroundMethodAerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
Self-citationDll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Self-citationRole of PFKFB3-Driven Glycolysis in Vessel Sprouting
De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,551
Self-citationSeven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
Lalwani, G. A., Rosenfeld, P. J., Fung, A. E., Dubovy, S. R., Michels, S., Feuer, W., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.024 · Cited by 880
Herrero-Mendez, A., Almeida, A., Fernández, E., Maestre, C., Moncada, S., & Bolaños, J. P. (2009) · Nature Cell Biology · doi:10.1038/ncb1881 · Cited by 844
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.21 · Cited by 685 · cited 1×
“However, insufficient efficacy and resistance limit its success (Ebos and Kerbel, 2011; Potente et al., 2011).”
BackgroundVAN SCHAFTINGEN, E., LEDERER, B., BARTRONS, R., & HERS, H. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb07039.x · Cited by 652
Raez, L. E., Papadopoulos, K., Ricart, A. D., Chiorean, E. G., DiPaola, R. S., Stein, M. N., Rocha Lima, C. M., Schlesselman, J. J., Tolba, K., Langmuir, V. K., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2045-1 · Cited by 543
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Self-citationRole of Endothelial Cell Metabolism in Vessel Sprouting
De Bock, K., Georgiadou, M., & Carmeliet, P. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.001 · Cited by 423
Self-citationThe Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis
Cummins, E. P., Seeballuck, F., Keely, S. J., Mangan, N. E., Callanan, J. J., Fallon, P. G., & Taylor, C. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.012 · Cited by 407 · cited 2×
“To quantify the histological signs of colitis, we used a histologic scoring method, taking into account the severity of inflammatory cell infiltration (dispersed, focal, or widespread), the extent of injury (mucosal, submucosal, or transmural), and crypt damage (basal, luminal, or entire crypt loss) (Cummins et al., 2…”
MethodVascular Endothelial Growth Factor A in Intraocular Vascular Disease
Miller, J. W., Le Couter, J., Strauss, E. C., & Ferrara, N. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.038 · Cited by 406
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Yalcin, A., Telang, S., Clem, B., & Chesney, J. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.003 · Cited by 405
Self-citationCoordinating cell behaviour during blood vessel formation
Geudens, I., & Gerhardt, H. (2011) · Development · doi:10.1242/dev.062323 · Cited by 376
Self-citationChesney, J., Mitchell, R., Benigni, F., Bacher, M., Spiegel, L., Al-Abed, Y., Han, J. H., Metz, C., & Bucala, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3047 · Cited by 287
Self-citationTargeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
Clem, B. F., O'Neal, J., Tapolsky, G., Clem, A. L., Imbert-Fernandez, Y., Kerr, D. A., Klarer, A. C., Redman, R., Miller, D. M., Trent, J. O., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0097 · Cited by 276
Self-citationVan de Veire, S., Stalmans, I., Heindryckx, F., Oura, H., Tijeras-Raballand, A., Schmidt, T., Loges, S., Albrecht, I., Jonckx, B., Vinckier, S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.039 · Cited by 256
Self-citationThe Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
Stewart, M. W. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.001 · Cited by 204
Locasale, J. W., & Cantley, L. C. (2010) · BMC Biology · doi:10.1186/1741-7007-8-88 · Cited by 198
The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge
Cavallaro, G., Filippi, L., Bagnoli, P., La Marca, G., Cristofori, G., Raffaeli, G., Padrini, L., Araimo, G., Fumagalli, M., Groppo, M., et al. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12049 · Cited by 193
Oxygen-induced retinopathy: a model for vascular pathology in the retina
Scott, A., & Fruttiger, M. (2010) · Eye · doi:10.1038/eye.2009.306 · Cited by 182
Krueger, J., Liu, D., Scholz, K., Zimmer, A., Shi, Y., Klein, C., Siekmann, A., Schulte-Merker, S., Cudmore, M., Ahmed, A., et al. (2011) · Development · doi:10.1242/dev.063933 · Cited by 177
Anticancer Agents That Counteract Tumor Glycolysis
Granchi, C., & Minutolo, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200176 · Cited by 166
Glucose-6-phosphate Dehydrogenase Modulates Vascular Endothelial Growth Factor-mediated Angiogenesis
Leopold, J. A., Walker, J., Scribner, A. W., Voetsch, B., Zhang, Y.-Y., Loscalzo, A. J., Stanton, R. C., & Loscalzo, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301293200 · Cited by 163
Are we there yet? Bevacizumab therapy for retinopathy of prematurity
Darlow, B. A., Ells, A. L., Gilbert, C. E., Gole, G. A., & Quinn, G. E. (2011) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2011-301148 · Cited by 119
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
Singh, M., & Ferrara, N. (2012) · Nature Biotechnology · doi:10.1038/nbt.2286 · Cited by 114
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation
Telang, S., Clem, B. F., Klarer, A. C., Clem, A. L., Trent, J. O., Bucala, R., & Chesney, J. A. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-95 · Cited by 107
Self-citationSacharidou, A., Stratman, A. N., & Davis, G. E. (2012) · Cells Tissues Organs · doi:10.1159/000331410 · Cited by 90
Seo, M., Kim, J., Neau, D. B., Sehgal, I., & Lee, Y. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024179 · Cited by 83
Endothelial cell metabolism and implications for cancer therapy
Harjes, U., Bensaad, K., & Harris, A. L. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.398 · Cited by 79
Hindryckx, P., Waeytens, A., Laukens, D., Peeters, H., Huysse, J. V., Ferdinande, L., Carmeliet, P., & Vos, M. D. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.37 · Cited by 40
Self-citationRed Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update
Climent, F., Roset, F., Repiso, A., & de la Ossa, P. P. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152909788488636 · Cited by 23
Retinopathy of prematurity—promising newer modalities of treatment
Niranjan, H. S., Benakappa, N., Reddy, K. R. B. K., Shivananda, & Kamath, M. V. (2012) · Indian Pediatrics · doi:10.1007/s13312-012-0028-2 · Cited by 14
Cited by
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,115
Notch Signaling in Development, Tissue Homeostasis, and Disease
Siebel, C., & Lendahl, U. (2017) · Physiological Reviews · doi:10.1152/physrev.00005.2017 · Cited by 978
Cantelmo, A. R., Conradi, L.-C., Brajic, A., Goveia, J., Kalucka, J., Pircher, A., Chaturvedi, P., Hol, J., Thienpont, B., Teuwen, L.-A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.006 · Cited by 659
Self-citationFatty acid carbon is essential for dNTP synthesis in endothelial cells
Schoors, S., Bruning, U., Missiaen, R., Queiroz, K. C. S., Borgers, G., Elia, I., Zecchin, A., Cantelmo, A. R., Christen, S., Goveia, J., et al. (2015) · Nature · doi:10.1038/nature14362 · Cited by 646
Self-citation
Metadata
- Authors
- Schoors, S., De Bock, K., Cantelmo, A. R., Georgiadou, M., Ghesquière, B., Cauwenberghs, S., Kuchnio, A., Wong, B. W., Quaegebeur, A., Goveia, J., Bifari, F., Wang, X., Blanco, R., Tembuyser, B., Cornelissen, I., Bouché, A., Vinckier, S., Diaz-Moralli, S., Gerhardt, H., Telang, S., Cascante, M., Chesney, J., Dewerchin, M., & Carmeliet, P.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 19
- Issue
- 1
- Pages
- 37-48
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W1975959171
- Cited by
- 529
- References
- 36
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.